We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

2 hedge funds and large institutions have $906K invested in Tonix Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

33% more capital invested

Capital invested by funds: $683K → $906K (+$224K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$438K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$217K
2
Victory Capital Management
Victory Capital Management
Texas
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$270K +$438K +1 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$234K – – –
BCM
3
Bridgeway Capital Management
Texas
$161K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$65K – – –
Jane Street
5
Jane Street
New York
$38K – – –
Northern Trust
6
Northern Trust
Illinois
$36K – – –
HighTower Advisors
7
HighTower Advisors
Illinois
$22K – – –
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$17K – – –
GCP
9
GSA Capital Partners
United Kingdom
$15K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$13K – – –
ARTA
11
A.R.T. Advisors
New York
$10K – – –
SFS
12
Sowell Financial Services
Arkansas
$9K – – –
EH
13
Equitable Holdings
New York
$6K – – –
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.06K – – –
CAN
15
Cetera Advisor Networks
California
$3K – – –
GWM
16
Geneos Wealth Management
Colorado
$2K – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$1K – – –
UBS Group
18
UBS Group
Switzerland
$1K – – –
Renaissance Technologies
19
Renaissance Technologies
New York
– -$217K – –
Victory Capital Management
20
Victory Capital Management
Texas
– -$12K – –

TNXP Hedge Fund Activity: Q2 2020 in Review

2 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q2 2020, worth a combined $906K — up 33% from $683K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new TNXP positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $438K. The largest seller was Renaissance Technologies, cutting an estimated $217K.

  • 2 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q2 2020, up from 1 in Q1 2020.
  • Funds reported $906K of Tonix Pharmaceuticals stock for Q2 2020, up 33% quarter-over-quarter.
  • 1 fund opened new Tonix Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +1 holder.
  • The largest Tonix Pharmaceuticals buyer in Q2 2020 was Citadel Advisors, an estimated $438K added.
  • The largest Tonix Pharmaceuticals seller in Q2 2020 was Renaissance Technologies, an estimated $217K sold.

Based on aggregated 13F filings for Q2 2020.